Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms

Coronaviruses infections, culminating in the recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic beginning in 2019, have highlighted the importance of effective vaccines to induce an antibody response with cross-neutralizing activity. COVID-19 vaccines have been rapidly deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantoni, Diego, Siracusano, Gabriel, Mayora-Neto, Martin, Pastori, Claudia, Fantoni, Tobia, Lytras, Spyros, Di Genova, Cecilia, Hughes, Joseph, Lopalco, Lucia, Temperton, Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864028/
https://www.ncbi.nlm.nih.gov/pubmed/36679903
http://dx.doi.org/10.3390/vaccines11010058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864028/
https://www.ncbi.nlm.nih.gov/pubmed/36679903
http://dx.doi.org/10.3390/vaccines11010058

Ejemplares similares